Abbott Laboratories (NYSE: ABT) will pay a premium of approximately $25 billion in cash and stock to acquire St. Jude Medical Inc. (NYSE: STJ). Shares of Abbott Laboratories plunged $2.67 to $41.16 while St. Jude Medical stock leaped $16.70 to $78.65.
Abbott Laboratories buys St. Jude Medical
April 28, 2016 at 14:31 PM EDT
